Table 2. Performance of the 4 TORRs to predict in-hospital mortality.
Goto | AHA-BLS | AHA-ALS | Shibahashi | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sna | Spb | PPVc | NPVd | Sn | Sp | PPV | NPV | Sn | Sp | PPV | NPV | Sn | Sp | PPV | NPV | |
Overall
95%CI |
53.8 53.3–54.2 |
91.4 90.4–92.4 |
99.0 98.9–99.1 |
11.2 10.8–11.5 |
79.0 78.6–79.4 |
80.0 79.5–82.2 |
98.5 97.5–99.6 |
19.6 19.0–20.3 |
48.6 48.2–49.0 |
88.3 87.2–89.4 |
98.5 98.3–98.6 |
9.8 9.5–10.2 |
35.0 34.6–35.4 |
94.2 93.4–95.0 |
99.0 98.8–99.1 |
8.4 8.1–8.7 |
Japan
95%CI |
56.9 56.4–57.4 |
94.0 93.0–94.9 |
99.4 99.3–99.5 |
11.3 10.8–11.7 |
81.1 80.7–81.4 |
85.7 84.3–87.1 |
98.9 98.9–99.1 |
20.9 20.1–21.7 |
48.3 47.8–48.8 |
91.6 90.5–92.7 |
99.0 98.9–99.1 |
9.4 9.0–9.7 |
38.9 38.5–39.4 |
94.1 93.2–95.0 |
99.1 99.0–99.3 |
8.3 7.9–8.6 |
Singapore
95%CI |
34.8 33.0–36.6 |
97.8 94.7–100 |
99.8 99.5–100 |
4.7 3.7–5.6 |
69.6 67.9–71.3 |
93.3 88.0–98.5 |
99.7 99.4–99.9 |
9.1 7.2–11.0 |
55.0 53.2–56.9 |
95.5 91.2–99.8 |
99.7 99.5–99.9 |
6.5 5.2–7.8 |
14.2 12.8–15.5 |
98.9 96.7–100 |
99.7 99.2–100 |
3.6 2.9–4.4 |
Thailand
95%CI |
20.9 14.9–27.0 |
100.0 100 -100 |
100.0 100 -100 |
7.5 3.2–11.7 |
66.9 59.8–73.9 |
81.8 59.0–100 | 98.3 95.9–100 |
13.6 5.4–21.9 |
54.1 46.6–61.5 |
81.8 59.0–100 |
97.9 95.0–100 |
10.2 3.9–16.6 |
10.5 5.9–15.0 |
100.0 100 -100 |
100.0 100 -100 |
6.7 2.9–10.5 |
UAE
95%CI |
35.2 30.0–40.0 |
92.3 77.8–100 |
99.2 97.7–100 |
4.8 2.2–7.5 |
61.9 56.9–66.8 |
84.6 65.0–100 |
99.1 97.9–100 |
7.3 3.1–11.4 |
56.1 51.1–61.2 |
92.3 77.8–100 |
99.5 98.6–100 |
6.9 3.2–10.7 |
6.5 4.0–9.1 |
100.0 100 -100 |
100.0 100 -100 |
3.7 1.7–5.6 |
Korea
95%CI |
38.6 37.3–40.0 |
83.8 80.8–86.7 |
95.2 94.3–96.1 |
14.0 12.9–15.2 |
70.9 69.6–72.2 |
63.6 59.7–67.5 |
94.2 93.5–95.0 |
20.7 18.9–22.6 |
40.8 39.4–42.1 |
78.2 74.8–81.5 |
94.0 93.0–95.0 |
13.6 12.5–14.8 |
15.2 14.2–16.2 |
96.1 94.5–97.7 |
97.0 95.8–98.2 |
11.9 11.0–12.9 |
Malaysia
95%CI |
33.5 26.9–40.1 |
80.0 44.9–100 |
98.5 95.6–100 |
3.0 0.0–6.0 |
82.2 76.9–87.6 |
40.0 0.0–82.9 |
98.2 96.1–100 |
5.4 0–13.0 |
56.3 49.4–63.3 |
60.0 17.1–100 |
98.2 95.8–100 |
3.4 0.0–7.0 |
6.09 2.8–9.4 |
80.0 44.9–100 |
92.3 77.8–100 |
2.1 0.0–4.0 |
Taiwan
95%CI |
59.9 58.0–61.9 |
79.3 73.5–85.1 |
97.3 96.5–98.2 |
13.5 11.5–15.5 |
74.1 72.4–75.9 |
67.6 60.9–74.2 |
96.7 95.8–97.5 |
17.1 14.4–19.8 |
60.1 58.1–62.0 |
75.5 69.4–81.7 |
96.9 96.0–97.8 |
13.0 11.0–15.0 |
40.6 38,6–42.6 |
86.2 81.2–91.1 |
97.4 96.4–98.4 |
10.3 8.8–11.8 |
aSn, sensitivity: Number of dead individuals that TORR suggested termination of resuscitation divided by the number of total dead individuals following OHCAs.
bSp, specificity: Number of individuals who survived that TORR suggested transportation divided by the total individuals who survived following OHCAs.
cPPV, positive predictive values: Number of dead individuals that TORR suggested termination of resuscitation divided by the total individuals that TORR suggested termination of resuscitation.
dNPV, negative predictive values: Number of individuals who survived that TORR suggested transportation divided by the total individuals that TORR suggested transportation.
AHA-BLS, American Heart Association Basic Life Support; AHA-ALS, American Heart Association Advanced Life Support.